Screener
Neuropace, Inc. NPCE Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Neuropace, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
FAQ
- What is Neuropace, Inc.'s asset turnover?
- Neuropace, Inc. (NPCE) reported asset turnover of 1× in Q2 2026.
- How has Neuropace, Inc.'s asset turnover changed year-over-year?
- Neuropace, Inc.'s asset turnover increased by 15.4% year-over-year, from 0.8× to 1×.
- What is the long-term trend for Neuropace, Inc.'s asset turnover?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s asset turnover has grown at a 19.1% compound annual growth rate (CAGR), from 0.5× to 1×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Neuropace, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude